Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures
Postgrad Med J
.
2021 Nov;97(1153):742-743.
doi: 10.1136/postgradmedj-2020-138447.
Epub 2020 Aug 26.
Authors
Tauqeer Hussain Mallhi
1
,
Yusra Habib Khan
1
,
Nasser Hadal Alotaibi
2
,
Abdulaziz Ibrahim Alzarea
2
,
Abdullah Salah Alanazi
2
,
Sumera Qasim
3
,
Muhammad Shahid Iqbal
4
,
Nida Tanveer
5
Affiliations
1
Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Kingdom of Saudi Arabia yusrahabib@ymail.com.
2
Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Kingdom of Saudi Arabia.
3
Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Kingdom of Saudi Arabia.
4
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, Kingdom of Saudi Arabia.
5
Women Medical Officer, Tehsil Headquarter Hospital, Jaranwala, Faisalabad, Punjab, Pakistan.
PMID:
32848085
PMCID:
PMC7448118
DOI:
10.1136/postgradmedj-2020-138447
No abstract available
Keywords:
Immunology; Infectious diseases; Medical journalism; Virology.
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / therapeutic use
COVID-19*
Drug Repositioning*
Humans
SARS-CoV-2
Substances
Antiviral Agents